GlassScriptPhysician profile
Barbara A Greco
NPI 1366428682
$3,282.83
in general payments reported to CMS, 2019-2025
19 companies · $1,960 in 2025
The $1,960 reported for 2025 was more than what 89% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $150 · 2021: $248 · 2022: $416 · 2023: $172 · 2025: $1,960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,960 · Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,960.00 |
| Food and Beverage | $171.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,181.77 | 2019-2025 | Lokelma, Farxiga |
| Alexion Pharmaceuticals, INC. | $177.54 | 2020-2021 | |
| Vifor Pharma, INC. | $126.25 | 2021-2023 | Veltassa |
| Opko Pharmaceuticals, LLC | $116.60 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $113.25 | 2021-2023 | |
| Akebia Therapeutics INC | $91.56 | 2019-2022 | |
| Glaxosmithkline, LLC. | $85.35 | 2022 | |
| Mallinckrodt Hospital Products INC. | $69.86 | 2022-2023 | Acthar |
| Eurofins Viracor, LLC | $67.01 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $65.25 | 2021-2022 | |
| Horizon Therapeutics Plc | $50.63 | 2022-2023 | Krystexxa |
| Fresenius USA Marketing, INC. | $36.34 | 2021-2022 | |
| Baxter Healthcare | $31.42 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.99 | 2023 | Gattex |
| Genzyme Corporation | $15.73 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $13.46 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $11.82 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Greco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.